Cargando…
2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
The nonmetabolizable glucose analog 2-deoxy-D-glucose (2-DG) has shown promising pharmacological activities, including inhibition of cancerous cell growth and N-glycosylation. It has been used as a glycolysis inhibitor and as a potential energy restriction mimetic agent, inhibiting pathogen-associat...
Autores principales: | Singh, Raman, Gupta, Vidushi, Kumar, Antresh, Singh, Kuldeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998157/ https://www.ncbi.nlm.nih.gov/pubmed/36911357 http://dx.doi.org/10.1155/2023/9993386 |
Ejemplares similares
-
1,2,3-Triazole β-lactam conjugates as antimicrobial agents
por: Kaur, Rajneesh, et al.
Publicado: (2020) -
Pharmacological immunosuppressive agents.
por: Salaman, J. R.
Publicado: (1981) -
2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis.
por: Bell, S. E., et al.
Publicado: (1998) -
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
por: Pajak, B., et al.
Publicado: (2019) -
Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010)